SEOM Clinical Guideline in ovarian cancer (2016)

被引：19
|
作者：
Santaballa, A. [1 ]
Barretina, P. [2 ]
Casado, A. [3 ]
Garcia, Y. [4 ]
Gonzalez-Martin, A. [5 ]
Guerra, E. [6 ]
Lainez, N. [7 ]
Martinez, J. [8 ]
Redondo, A. [9 ]
Romero, I. [10 ]
机构：
[1] Hosp Univ & Politecn La Fe, Serv Oncol Med, Avda Fernando Abril Martorell 106, Valencia 46026, Spain
[2] Inst Catala Oncol, Serv Oncol Med, Girona, Spain
[3] Hosp Clin Univ, Serv Oncol Med, Madrid, Spain
[4] Corp Sanitaria Parc Tauli, Serv Oncol Med, Sabadell, Spain
[5] MD Anderson Canc Ctr, Serv Oncol Med, Madrid, Spain
[6] Hosp Univ Ramon & Cajal, Serv Oncol Med, Madrid, Spain
[7] Complejo Hosp Navarra, Serv Oncol Med, Pamplona, Spain
[8] Hosp Univ Virgen de la Arrixaca, Serv Oncol Med, Murcia, Spain
[9] Hosp Univ La Paz, Serv Oncol Med, Madrid, Spain
[10] Fdn Inst Valenciano Oncol, Serv Oncol Med, Valencia, Spain
来源：
CLINICAL & TRANSLATIONAL ONCOLOGY | 2016年 / 18卷 / 12期
关键词：
Ovarian cancer; Treatment guidelines; First line; Recurrent disease; PHASE-III TRIAL; PEGYLATED LIPOSOMAL DOXORUBICIN; RANDOMIZED-TRIAL; OPEN-LABEL; EXPLORATORY ANALYSIS; EPITHELIAL OVARIAN; PRIMARY PERITONEAL; PRIMARY SURGERY; FALLOPIAN-TUBE; CHEMOTHERAPY;
D O I：
10.1007/s12094-016-1588-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Despite remarkable advances in the knowledge of molecular biology and treatment, ovarian cancer (OC) is the first cause of death due to gynecological cancer and the fifth cause of death for cancer in women in Spain. The aim of this guideline is to summarize the current evidence and to give evidence-based recommendations for clinical practice.
引用
收藏
页码：1206 / 1212
页数：7
相关论文
共 50 条
  • [41] Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    Gonzalez-Martin, A.
    Harter, P.
    Leary, A.
    Lorusso, D.
    Miller, R. E.
    Pothuri, B.
    Ray-Coquard, I.
    Tan, D. S. P.
    Bellet, E.
    Oaknin, A.
    ANNALS OF ONCOLOGY, 2023, 34 (10) : 833 - 848
  • [42] Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup
    Vergote, Ignace
    Gonzalez-Martin, Antonio
    Lorusso, Domenica
    Gourley, Charlie
    Mirza, Mansoor Raza
    Kurtz, Jean-Emmanuel
    Okamoto, Aikou
    Moore, Kathleen
    Kridelka, Frederic
    McNeish, Iain
    Reuss, Alexander
    Votan, Benedicte
    du Bois, Andreas
    Mahner, Sven
    Ray-Coquard, Isabelle
    Kohn, Elise C.
    Berek, Jonathan S.
    Tan, David S. P.
    Colombo, Nicoletta
    Zang, Rongyu
    Concin, Nicole
    O'Donnell, Dearbhaile
    Rauh-Hain, Alejandro
    Herrington, C. Simon
    Marth, Christian
    Poveda, Andres
    Fujiwara, Keiichi
    Stuart, Gavin C. E.
    Oza, Amit M.
    Bookman, Michael A.
    LANCET ONCOLOGY, 2022, 23 (08) : E374 - E384
  • [43] Bevacizumab in the Treatment of Ovarian Cancer
    Heitz, Florian
    Harter, Philipp
    Barinoff, Jana
    Beutel, Bianca
    Kannisto, Paevi
    Grabowski, Jacek P.
    Heitz, Julia
    Kurzeder, Christian
    du Bois, Andreas
    ADVANCES IN THERAPY, 2012, 29 (09) : 723 - 735
  • [44] SEOM clinical guidelines for endometrial cancer (2017)
    Santaballa, A.
    Matias-Guiu, X.
    Redondo, A.
    Carballo, N.
    Gil, M.
    Gomez, C.
    Gorostidi, M.
    Gutierrez, M.
    Gonzalez-Martin, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (01) : 29 - 37
  • [45] Updated 2016 recommendations for the clinical practice of Nice/Saint-Paul-de-Vence in ovarian cancer and advanced cervical cancer
    Joly, Florence
    Querleu, Denis
    Namer, Moise
    Pujade-Lauraine, Eric
    BULLETIN DU CANCER, 2017, 104 : S1 - S4
  • [46] Bevacizumab in ovarian cancer: Focus on clinical data and future perspectives
    Colombo, Nicoletta
    Conte, Pier Franco
    Pignata, Sandro
    Raspagliesi, Francesco
    Scambia, Giovanni
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 97 : 335 - 348
  • [47] SEOM clinical guidelines for the treatment of pancreatic cancer
    Gomez-Martin, Carlos
    Hidalgo, Manuel
    Tabernero, Josep
    Isla, Dolores
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (08) : 528 - 535
  • [48] SEOM clinical guidelines for treatment of prostate cancer
    Arranz Arija, Jose Angel
    Cassinello Espinosa, Javier
    Climent Duran, Miguel Angel
    Rivera Herrero, Fernando
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (07) : 520 - 527
  • [49] SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018)
    Gomez-Espana, M. A.
    Gallego, J.
    Gonzalez-Flores, E.
    Maurel, J.
    Paez, D.
    Sastre, J.
    Aparicio, J.
    Benavides, M.
    Feliu, J.
    Vera, R.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (01) : 46 - 54
  • [50] Improved Survival from Ovarian Cancer in Patients Treated in Phase III Trial Active Cancer Centres in the UK
    Khoja, L.
    Nolan, K.
    Mekki, R.
    Milani, A.
    Mescallado, N.
    Ashcroft, L.
    Hasan, J.
    Edmondson, R.
    Winter-Roach, B.
    Kitchener, H. C.
    Mould, T.
    Hutson, R.
    Hall, G.
    Clamp, A. R.
    Perren, T.
    Ledermann, J.
    Jayson, G. C.
    CLINICAL ONCOLOGY, 2016, 28 (12) : 760 - 765
12345